CDK5 and lung carcinoma: Similar to our results, in cancer such as lung cancer and pancreatic cancer, CDK5 and p35 overexpression were frequently but not solely associated with gene mutation.10, 16 These researches indicated that CDK5 may serve as a universal tumor biomarker to identify patients with poor clinical outcomes.